8
eBook: COVID-19 pathogenesis, prevention and treatment
Complete the form below to get your free COVID-19 pathogenesis, prevention and treatment eBook. Receive three free articles from our…
Browsing: Clinical > Vaccines
0
Advancing the development of therapeutics against infectious diseases with optimized protein expression systems
Novel and emerging infectious diseases can be a serious threat to human health and the global economy. To mitigate these…
0
What effect will SARS-CoV-2 variants have on vaccine efficacy?
The ‘inevitable’ domination of novel SARS-CoV-2 variants from Brazil, South Africa and the UK could result in less effective COVID-19…
0
How effective are the COVID-19 vaccines for those who are immunocompromised?
Up to 5000 immunocompromised people from across the UK are set to be vaccinated as part of the Octave study…
0
The impact of the first dose of the COVID-19 vaccines
The first national population-level study has shed light on the effect of the first dose of the COVID-19 vaccine. The…
0
Pfizer/BioNTech COVID-19 vaccine approved for use by UK regulator
Pfizer and BioNTech’s COVID-19 vaccine has been approved for use by the UK’s regulator, MHRA, making it the first COVID-19…
0
What are the advantages of the Oxford—AstraZeneca COVID-19 vaccine?
While the latest set of interim vaccine results from Oxford University and AstraZeneca include an efficacy score of 70%, significantly…
0
Moderna’s COVID-19 vaccine demonstrates 94.5% efficacy
Just 1 week after Pfizer and BioNTech’s early Phase III trial data were released, more good news comes from Moderna’s…
0
Pfizer and BioNTech’s COVID-19 vaccine 90% effective in Phase III trial
The first set of data from Pfizer (NY, USA) and BioNTech’s (Mainz, Germany) Phase III clinical trial for their COVID-19…
0
Accelerate your COVID-19 bioanalytical research while saving time and reducing cost
Wednesday 18 November 2020 11:00 [EST] 08:00 [PST] 16:00 [GMT] Alternative time zones REGISTER NOW The pharmaceutical industry is in…